Characteristics and outcomes of chronic obstructive pulmonary disease in never smokers in Denmark: A prospective population study

The Lancet Respiratory Medicine

Volumn 1, Issue 7, 2013, Pages 543-550

  Thomsen, Mette ^a,d   Nordestgaard, Børge G ^a,b,d   Vestbo, Jørgen ^f,g   Lange, Peter ^a,b,c,d,e  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b FREDERIKSBERG HOSPITAL   (Denmark)

^c HVIDOVRE HOSPITAL   (Denmark)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

^e UNIVERSITY OF COPENHAGEN   (Denmark)

^f ODENSE UNIVERSITY HOSPITAL   (Denmark)

^g UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN;

ADULT; AGED; ARTICLE; ASTHMA; CARDIOVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; COMORBIDITY; CONTROLLED STUDY; DENMARK; DISEASE SEVERITY; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HOSPITAL ADMISSION; HUMAN; LUNG CANCER; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MORTALITY; NONSMOKER; PNEUMONIA; POPULATION RESEARCH; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RISK ASSESSMENT; SELF REPORT; SMOKING; SMOKING HABIT; SPIROMETRY; SYMPTOM; DYSPNEA; EPIDEMIOLOGY; HOSPITALIZATION; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTOR; STATISTICS AND NUMERICAL DATA; VERY ELDERLY; VITAL CAPACITY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; DENMARK; DYSPNEA; FORCED EXPIRATORY VOLUME; HOSPITALIZATION; HUMANS; MIDDLE AGED; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; SMOKING; VITAL CAPACITY; YOUNG ADULT;

EID: 84883448491     PISSN: 22132600     EISSN: None     Source Type: Journal    
DOI: 10.1016/S2213-2600(13)70137-1     Document Type: Article

References (30)

1. Salvi SS, Barnes PJ Chronic obstructive pulmonary disease in non-smokers. Lancet 2009, 374:733-743.
2. Behrendt CE Mild and moderate-to-severe COPD in nonsmokers: distinct demographic profiles. Chest 2005, 128:1239-1244.
3. Celli BR, Halbert RJ, Nordyke RJ, Schau B Airway obstruction in never smokers: results from the Third National Health and Nutrition Examination Survey. Am J Med 2005, 118:1364-1372.
4. Lamprecht B, McBurnie MA, Vollmer WM, et al. COPD in never smokers: results from the population-based burden of obstructive lung disease study. Chest 2011, 139:752-763.
5. Blanc PD, Iribarren C, Trupin L, et al. Occupational exposures and the risk of COPD: dusty trades revisited. Thorax 2009, 64:6-12.
6. Downs SH, Schindler C, Liu LJ, et al. Reduced exposure to PM10 and attenuated age-related decline in lung function. N Engl J Med 2007, 357:2338-2347.
7. Eisner MD, Anthonisen N, Coultas D, et al. An official American Thoracic Society public policy statement: Novel risk factors and the global burden of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2010, 182:693-718.
8. Yin P, Jiang CQ, Cheng KK, et al. Passive smoking exposure and risk of COPD among adults in China: the Guangzhou Biobank Cohort Study. Lancet 2007, 370:751-757.
9. Svanes C, Sunyer J, Plana E, et al. Early life origins of chronic obstructive pulmonary disease. Thorax 2010, 65:14-20.
10. Bakke PS, Ronmark E, Eagan T, et al. Recommendations for epidemiological studies on COPD. Eur Respir J 2011, 38:1261-1277.
11. Vestbo J, Hurd SS, Agusti AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013, 187:347-365.
12. Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J 2005, 26:948-968.
13. Lokke A, Marott JL, Mortensen J, Nordestgaard BG, Dahl M, Lange P New Danish reference values for spirometry. Clin Respir J 2012.
14. Thomsen M, Dahl M, Lange P, Vestbo J, Nordestgaard BG Inflammatory biomarkers and comorbidities in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2012, 186:982-988.
15. Thomsen M, Ingebrigtsen T, Marott JL, et al. Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease. JAMA 2013, 309:2353-2361.
16. Storm HH Completeness of cancer registration in Denmark 1943-1966 and efficacy of record linkage procedures. Int J Epidemiol 1988, 17:44-49.
17. Storm HH, Michelsen EV, Clemmensen IH, Pihl J The Danish Cancer Registry-history, content, quality and use. Dan Med Bull 1997, 44:535-539.
18. Thomsen RW, Lange P, Hellquist B, et al. Validity and underrecording of diagnosis of COPD in the Danish National Patient Registry. Respir Med 2011, 105:1063-1068.
19. Juul K, Tybjaerg-Hansen A, Schnohr P, Nordestgaard BG Factor V Leiden and the risk for venous thromboembolism in the adult Danish population. Ann Intern Med 2004, 140:330-337.
20. Lange P, Parner J, Vestbo J, Schnohr P, Jensen G A 15-year follow-up study of ventilatory function in adults with asthma. N Engl J Med 1998, 339:1194-1200.
21. Janus ED, Phillips NT, Carrell RW Smoking, lung function, and alpha 1-antitrypsin deficiency. Lancet 1985, 1:152-154.
22. Tobin MJ, Cook PJ, Hutchison DC Alpha 1 antitrypsin deficiency: the clinical and physiological features of pulmonary emphysema in subjects homozygous for Pi type Z. A survey by the British Thoracic Association. Br J Dis Chest 1983, 77:14-27.
23. Hole DJ, Watt GC, Davey-Smith G, Hart CL, Gillis CR, Hawthorne VM Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study. BMJ 1996, 313:711-715.
24. Lange P, Nyboe J, Appleyard M, Jensen G, Schnohr P Spirometric findings and mortality in never-smokers. J Clin Epidemiol 1990, 43:867-873.
25. Yanbaeva DG, Dentener MA, Creutzberg EC, Wesseling G, Wouters EF Systemic effects of smoking. Chest 2007, 131:1557-1566.
26. Danesh J, Wheeler JG, Hirschfield GM, et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 2004, 350:1387-1397.
27. Barnes PJ, Celli BR Systemic manifestations and comorbidities of COPD. Eur Respir J 2009, 33:1165-1185.
28. Anthonisen NR, Connett JE, Enright PL, Manfreda J Hospitalizations and mortality in the Lung Health Study. Am J Respir Crit Care Med 2002, 166:333-339.
29. Ezzati M Indoor air pollution and health in developing countries. Lancet 2005, 366:104-106.
30. Coultas DB, Mapel D, Gagnon R, Lydick E The health impact of undiagnosed airflow obstruction in a national sample of United States adults. Am J Respir Crit Care Med 2001, 164:372-377.